InvestorTransforming businesses for long-term success.
The Longevity Fund
The Longevity Fund is a venture capital firm based in San Francisco, focusing on investments in biotechnology and health tech companies that aim to extend healthy human lifespan and address age-related diseases. Founded in 2011, it has a legacy portfolio that includes several notable longevity companies.
Online destinations
Find The Longevity Fund online
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Official links
Pages the organization runs itself.
Overview
The Longevity Fund, founded in 2011 by Laura Deming, is a San Francisco-based venture capital firm dedicated to funding companies that develop drugs for age-related diseases, with the goal of increasing healthy human lifespan. The organization has been instrumental in backing some of the first longevity companies to go public and is launching a new fund named age1. The fund emphasizes the importance of founder-driven companies, believing that mission-oriented entrepreneurs are essential for building successful longevity ventures. The Longevity Fund initiated an accelerator program in 2018 to support these companies, testing the hypothesis that they are crucial for advancing the longevity sector.
Focus
The Longevity Fund primarily invests in the longevity sector, particularly in companies that are developing therapeutics for age-related diseases. The organization emphasizes the importance of founder-driven companies, believing that mission-oriented entrepreneurs are crucial for building successful longevity ventures. The fund supports innovative drug development approaches that challenge traditional biotech norms.
Support
The Longevity Fund adds value to its portfolio companies by providing strategic guidance and support tailored to the unique challenges of the longevity biotech sector. The fund emphasizes the importance of founder-driven initiatives and aims to foster innovative approaches to drug development that can lead to significant advancements in treating age-related diseases.
Questions
What are The Longevity Fund's investment criteria?
The Longevity Fund invests in founder-led companies developing therapeutics for age-related diseases, primarily in the Seed, Series A, and Series B stages. The fund emphasizes innovative drug development approaches that challenge traditional biotech norms.
How can I pitch to The Longevity Fund?
Founders can pitch their companies by visiting the fund's website at longevity.vc and submitting their information through the provided channels. It is recommended to include a clear explanation of the company's mission and how it aligns with the fund's focus on longevity.
What makes The Longevity Fund different from other VCs?
The Longevity Fund specifically targets the longevity biotech sector and emphasizes the importance of founder-driven companies. The firm has a history of backing early longevity companies that have gone public, showcasing its commitment to this niche.
What is the geographic scope of The Longevity Fund?
The Longevity Fund primarily invests in companies based in the United States, but its relevance extends globally within the biotech community.
What is the typical check size for investments?
The Longevity Fund typically invests between $0 and $1 million in its portfolio companies, focusing on early-stage funding.
What kind of support does The Longevity Fund provide to its portfolio companies?
The fund provides strategic guidance and support tailored to the unique challenges of the longevity biotech sector, emphasizing the importance of founder-driven initiatives.
Check your startup’s fit
Check your startup’s fit with The Longevity FundSimilar investors
Organizations that do similar work to The Longevity Fund.
Investor
InvestorFounders Fund is a venture capital firm based in the United States, founded in 2005. It invests in technology companies across various sectors and stages.
Investor
InvestorGlobal private investment firm with diverse strategies.
Superscout Pro
Find faster. Show up verified. Keep your deals private.
$99a year, or $12 a month
Get Pro- Search that narrowsInvestors, programs, accelerators, incubators and studios, by stage, sector and place.
- A verified profileThe people you reach know you are who you say you are.
- A private deal vaultThe startups you are watching, with your notes and your reasons. Nobody else's eyes.
Is this page right?Reviewed · How the research works